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Obesity is associated with lower concentrations of vitamin D
[25(OH)D3] in children, adolescents and adults, but it remains
unclear whether maternal adiposity inﬂuences maternal and foetal
concentrations of this vitamin. The objective of this cross-sectional
study was to assess the relationship between maternal adiposity
and maternal and cord blood concentrations of vitamin D. It
involved 101 motherenewborn pairs from a public maternity in
Sao Paulo city, Brazil. Demographic, socioeconomic and obstetric
data, as well as anthropometry, physical activity and vitamin D
supplementation during pregnancy, were investigated. Maternal
adiposity was assessed by bioelectrical impedance. Maternal and
cord blood concentrations of vitamin D were measured by high-
performance liquid chromatography. Two multiple linear regres-
sion models that included maternal and cord blood vitamin D
concentrations as outcomes and maternal adiposity as indepen-
dent variable were used. No association was observed between
maternal adiposity and maternal or cord blood concentrations of
vitamin D. Maternal vitamin D concentration was associated with
race, physical activity and vitamin D supplementation (adj.
R2 ¼ 0.74). Cord blood vitamin D concentration was associated
with maternal vitamin D concentration (adj. R2 ¼ 0.24). Although
fat mass quantiﬁcation is important to understand vitamin D sta-
tus during all stages of life, this may not be true in pregnancy as
race, vitamin D supplementation and physical activity appeared toSchool of Public Health, University of S~ao Paulo, Avenida Dr. Arnaldo, 715,
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metabolism in pregnancy may elucidate how or if adiposity in-
ﬂuences maternal vitamin D status and how it impacts vitamin D
transport to the foetus.
© 2016 The Authors. Published by Elsevier Ltd on behalf of
European Society for Clinical Nutrition and Metabolism. This is an
open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
In recent years, there has been growing interest in vitamin D [25(OH)D3] because of the global high
prevalence of vitamin D insufﬁciency and deﬁciency, and increasing evidence associating deﬁcits of
this vitamin with negative health outcomes [1]. Low concentrations of vitamin D may lead to hypo-
calcaemic seizures, dilated cardiomyopathy, skeletal myopathy, congenital and infantile rickets, and
osteomalacia. In addition to the importance of vitamin D for calcium and phosphorus homeostasis
during bone growth, mineralization and neuromuscular activity [2], low concentrations of this vitamin
have also been associated with cancer [3], cardiovascular diseases [4], diabetes and metabolic syn-
drome [5], lung disorders [6], and pregnancy complications [7].
The inverse association between vitamin D concentrations and obesity in children, adolescents and
adults is well documented [8e10]. Adipose tissue is known to sequester vitamin D, consequently
reducing its plasma concentrations and interfering with its bioavailability [11,12]. However, only few
studies have explored vitamin D in pregnant women and their newborns. In a study involving 398
pregnant women from Pennsylvania, United States, an inverse relationship was observed between
maternal obesity (body mass index, BMI  30) and maternal and blood concentrations of vitamin D
[13]; however, subsequent studies did not conﬁrm this ﬁnding. A study conducted in Chicago, United
States, on 61 motherenewborn pairs [14] showed that maternal obesity was not associated with
vitamin D concentration in the third trimester of pregnancy. However, vitamin D supplementationwas
not investigated during pregnancy. In a prospective study involving 105 pregnant Swedishwomen [15],
obesewomen had lower concentrations of vitamin D in the ﬁrst trimester, but therewas no statistically
signiﬁcant difference in vitamin D concentrations between obese and eutrophic women in the second
and third trimesters of pregnancy.
Previous studies have shown that cord blood concentration of vitamin D is positively associated
with maternal concentrations of this vitamin [16,17], but there is speculation whether or not maternal
obesity can impair placental transport of vitamin D. Josefson et al. [14] demonstrated that, irrespective
of maternal vitamin D concentration, obese women transferred less vitamins to their foetus than
eutrophic women. However, a recent prospective study involving 202 pregnant women found no as-
sociation between maternal BMI and cord blood concentration of vitamin D [17].
There are controversial and insufﬁcient data to conﬁrm that maternal obesity/adiposity reduces
maternal and/or newborn vitamin D concentrations. To our knowledge, no study has evaluated the
effect of maternal adiposity per se, and not only of BMI, on cord blood vitamin D concentration.
Therefore, the objective of this study was to assess the relationship between maternal adiposity and
maternal and cord blood concentrations of vitamin D.2. Materials and methods
2.1. Study design and participants
In this cross-sectional study, 101 women and their newborns apparently healthy were selected
consecutively between April and June 2013 from a large public maternity unit in S~ao Paulo
city, Brazil, through their detailed hospital records and antenatal cards. Exclusion criteria were
adolescence, multiple pregnancy, diabetes, hypertension, hormonal disorders, chronic infectious
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of the newborn.
2.2. Data collection
Shortly after delivery, the women were invited to participate in the study and were asked about
demographic, socioeconomic and obstetric factors. A socioeconomic questionnaire was applied,
assigning scores to maternal education and housing conditions (television sets, CD players, vehicles,
washing machines, DVD players, refrigerators/freezers, and bathrooms). The following obstetric data
were collected from the mothers: pre-pregnancy BMI, maternal date of birth, maternal weight in all
antenatal visits, newborn date and time of birth, type of delivery, sex, gestational age (GA), birth
weight, and length. The data were veriﬁed against antenatal cards and hospital records.
Gestational age was determined by a combination of ultrasonography performed up to week 20 of
gestation, the Capurro method [18] determined within 12e48 h after delivery, and the date of the last
menstrual period. When there was a discrepancy of one week or less between at least two of the GA
determinations assessed by the three different methods, one of themwas chosen, giving preference to
the order of the methods cited above.
Maternal physical activity was investigated using the long form of the International Physical Activity
Questionnaire (IPAQ), validated for the Brazilian population [19]. The data were analysed according to
the Guidelines for Data Processing and Analysis of the IPAQ [20].
2.3. Anthropometry and body composition of the mothers and newborns
Maternal height was measured with a Tonelli stadiometer (120A, Criciúma, Santa Catarina, Brazil).
Maternal weight and adiposity were evaluated with a bioelectrical impedance analyser (Inbody370,
Biospace®, Gangnam-Gu, Seoul, Korea). The nutritional status of the mothers was determined based on
BMI according to the WHO classiﬁcation: underweight: < 18.5 kg/m2; normal weight: 18.5e24.99 kg/
m2; overweight: 25.0e29.99 kg/m2; obese:  30.0 kg/m2. Maternal adiposity was assessed by fat mass
(kg) and fat mass percentage.
Newborn length was measured with a Seca® infantometer (416, Hamburg, Hamburg, Germany) to
the nearest 0.1 cm. Weight (to the nearest 1 g) and body composition were assessed by air displace-
ment plethysmography (PEA POD®, Cosmed, San Francisco, CA, USA). All measurements were per-
formed 24e72 h after birth.
2.4. Vitamin D [25(OH)D3]
Fasting cord and maternal blood samples were collected into EDTA vacutainers (Becton Dickinson,
Rutherford, NJ, USA) up to 10 min and 24e72 h after delivery, respectively. The samples were centri-
fuged for 15 min at 960 g (Fanem®, Excelsa II 206 BL, S~ao Paulo, SP, Brazil) and plasma was stored at
70 C until the time of analysis. Vitamin D was extracted from plasma (500 mL) by the addition of
25 mL HPLC ethanol solution (Merck, Hessen, Darmstadt, Germany) and incubation for 10 min at room
temperature. After this period, 500 mL of the mobile phase (methanol:isopropanol, 98:2, v/v) (Merck,
Hessen, Darmstadt, Germany) was added and the mixture was vortexed for 15 s (Biomixer MVS-1,
Jersey city, NJ, USA). One milliliter hexane (Merck, Hessen, Darmstadt, Germany) was added and the
ﬁnal solution was mixed (60 s). The solution was centrifuged (Eppendorf® 5415C, Hamburg, Hamburg,
Germany) for 4 min at 960 g and the supernatant (250 mL) was transferred to a clean test tube. This
procedure was repeated twice and evaporated for 10 min at room temperature in a Centrivap
concentrator (Labconco, Kansas City, MO, USA). The extracted vitamin was reconstituted in 250 mL
methanol, submitted to ultrasonic agitation for 5 min, and ﬁltered through polypropylene membranes
(0.45 mM). Analysis was performed in an LC-20AT HPLC system (Shimadzu, Inc., Chiyoda-Ku, Tokyo,
Japan), equipped with an SIL-20AC automatic injector, CBM-20A controller, CTO-20A column oven
(40 C), and SPD-M20A diode array detector, using a Luna C18 separation column (250.0  4.6 mm, 5-
mm particle size; Phenomenex, Torrance, CA, USA). The ﬂow rate of the mobile phase was 0.8 mL/min
for 15 min. The retention time for 25(OH)D3 was 8.5 min and the injection volume was 100 mL. A 5-
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96.15%.
The concentrations of 25(OH)D3 were determined according to Neyestani et al. [21] and blood
samples were collected during the same season to avoid differences in vitamin concentrations. The
reference values used to deﬁne vitamin D insufﬁciency and deﬁciency in mothers and newborns were
<20 ng/mL (50 nmol/L) and 21e29 ng/mL (52.5e72.5 nmol/L), respectively [22].2.5. Ethical aspects
The study was approved by the Ethics Committees of the School of Public Health, University of S~ao
Paulo, and of the Dr. Mario de Moraes Altenfelder Silva Maternity Unit. All mothers gave written
informed consent for themselves and their newborns.2.6. Statistical analysis
Data were analysed using the Statistical Package for the Social Science for Windows® (version 20.0;
SPSS, Inc., Chicago, IL, USA). The KolmogoroveSmirnov test was used to determine whether the
outcome variables (maternal and cord blood vitamin D) followed a normal distribution. Since no
normal distribution was observed, the data were log transformed. Variance homogeneity was veriﬁed
by the Levene test. Two multivariate linear regression models were developed to evaluate the asso-
ciations between maternal adiposity and maternal and cord blood concentrations of vitamin D using
backward stepwise selection.
The relationship of maternal vitamin D concentration (outcome) with the independent variables -
maternal adiposity and confounders (maternal age, race, physical activity, parity, height,
pre-pregnancy BMI, weight gain, and vitamin D supplementation in pregnancy) was determined by
univariate linear regression. Variables with p  0.20 in the univariate analysis were selected for entry
into the ﬁrst multivariate linear regression model.
The relationship of cord blood vitamin D concentration (outcome) with the independent variables -
maternal adiposity and confounders (maternal age, race, physical activity, parity, height,
pre-pregnancy BMI, weight gain, vitamin D supplementation in pregnancy, maternal vitamin D con-
centration, GA, and newborn sex, weight, length and fat mass percentage) was determined by uni-
variate linear regression. Variables with p  0.20 in the univariate analysis were selected for entry into
the second multivariate linear regression model.
A p value  0.05 was considered signiﬁcant.
3. Results
Table 1 shows the characteristics of the 101motherenewborn pairs included in the study. Themean
maternal age (SD) was 25.81 (5.15) years and 58.4% of the mothers were black or mulatto. Most women
(69.3%) were classiﬁed as belonging to socioeconomic stratum “C” (middle class in Brazil), with a mean
(SD) monthly per capita income of R$ 608.73 (approximately US$ 196.36). Almost half of the women
(42.6%) had low levels of physical activity, with an average time spent sitting of 4.25 h onweekdays and
of 3.59 h onweekends. Most womenwere multiparous (65.3%) and overweight or obese (69.3%) at the
beginning of pregnancy. The mean (SD) weight gain during pregnancy was 14.3 (5.39) kg, and mean
(SD) fat mass and fat mass percentage were 24.26 (10.53) kg and 32.32% (7.74), respectively. Almost 9%
of the women used vitamin D supplementation during pregnancy. Mean (SD) concentrations of
maternal and cord vitamin D were 30.86 (21.17) ng/mL and 10.75 (6.95) ng/mL, respectively.
More than half of the newborns (51.5%) were female, with a mean GA (SD) of 39.65 (1.37) weeks,
birth weight of 3322.46 (458.4) g, length of 48.71 (2.04) cm, fat mass of 0.27 (0.16) kg, and fat mass
percentage of 8.55 (4.37).
Figure 1 shows the distribution of maternal and cord blood concentrations of vitamin D on a log-
arithmic scale. Vitamin D insufﬁciency and deﬁciency were 15.4% and 41.4% in mothers, respectively,
and 7% and 88.4% in newborns (Fig. 2).
Table 1
Maternal and newborn characteristics (n ¼ 101).
Maternal characteristics N % Mean (SD)
Age (years) 101 100 25.81 (5.15)
Race
Black 17 16.8
Mulatto 42 41.6
White 41 40.6
Unknown 1 1.0
Per capita monthly income (R$)* 70 69.3 608.73 (434.91)
Level of physical activity
Low 43 42.6
Moderate 35 34.7
High 11 10.9
Unknown 12 11.9
Parity
Primiparous 35 34.7
Multiparous 66 65.3
Height (cm) 98 97.0 159.94 (6.86)
Pre-pregnancy BMI (Kg/m2) 99 98.0 27.79 (5.61)
<18.50 (underweight) 3 3.0
18.50e24.99 (normal range) 26 25.7
25.00e29.99 (overweight) 42 41.6
30.00 (obese) 28 27.7
Unknown 2 2.0
Weight gain in pregnancy (Kg) 81 80.2 14.30 (5.39)
Fat mass (Kg) 99 98.0 24.26 (10.53)
Fat mass (%) 99 98.0 32.32 (7.74)
Vitamin D concentration (ng/mL) 99 98.0 30.65 (21.17)
Vitamin D supplementation
No 92 91.1
Yes 9 8.9
Newborn's characteristics
Sex
Male 49 48.5
Female 52 51.5
Gestational age (weeks) 101 39.65 (1.37)
Birth weight (g) 101 3322.46 (458.40)
Length at birth (cm) 97 48.71 (2.04)
Fat mass (Kg) 101 0.27 (0.16)
Fat mass (%) 101 8.55 (4.37)
Cord vitamin D concentration (ng/mL) 86 10.75 (6.95)
*US$1.00 ¼ R$2.14.
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maternal (p ¼ 0.55) or cord blood (p ¼ 0.79) concentrations of vitamin D. Race (p ¼ 0.017), physical
activity (p ¼ 0.009) and vitamin D supplementation (p ¼ 0.02) were associated with maternal vitamin
D concentration (adj. R2¼ 0.737) in the multivariate regression model, considering maternal vitamin D
concentration as outcome (Table 2).
Univariate linear regression analysis showed an association between cord blood and maternal
concentrations of vitamin D (p ¼ 0.019). The relationship remained signiﬁcant after adjustment for
confounding variables in the multivariate regression model (adj. R2 ¼ 0.235), considering cord blood
vitamin D concentration as outcome (Table 3).4. Discussion
This study found no associations between maternal adiposity and maternal or cord blood con-
centrations of vitamin D. An association between maternal obesity and vitamin D concentration has
Figure 1. Distribution of maternal (n ¼ 99) and cord blood (n ¼ 86) concentrations of vitamin D on a logarithmic scale.
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Figure 2. Distribution (%) of mothers (n ¼ 99) and newborns (n ¼ 86) according to their vitamin D status.
F.F.A. Sim~oes et al. / Clinical Nutrition Experimental 9 (2016) 3e12 9been suggested in a previous cohort study [13]. The authors observed a negative relationship between
pre-pregnancy BMI and vitamin D concentration in pregnant women at 4e22 week gestation and at
term after controlling for race, GA, vitamin D supplementation, physical activity before pregnancy, and
maternal age. Similar to other cross-sectional [14,22] and longitudinal studies [15,17], our results did
not show a relationship between maternal obesity and vitamin D concentration. However, only one of
those studies investigated adiposity and was not limited to pre-pregnancy BMI [15]. Since the
reduction of plasma vitamin D concentrations in obese individuals is explained primarily by the
sequestration of this vitamin by adipose tissue [11,12], it is likely that fat mass quantiﬁcation is
fundamental to understand this relationship in future studies.
Possible explanations for the lack of an association between adiposity and maternal vitamin D
concentration are: 1) changes in vitamin D metabolism during pregnancy [22,23], 2) the lack of
determination of vitamin D protein ligands [24], and 3) increased total body water content (haemo-
dilution) observed during pregnancy. These mechanisms remain to be elucidated.
In this study, maternal vitamin D concentration was associated with race, vitamin D supplemen-
tation and physical activity in pregnancy. Race is known to have an independent and important impact
on blood vitamin D concentration [25]. As suggested by Karlsson et al. [15], this variable should always
be documented in studies involving maternalefoetal vitamin D status since it can cause misinter-
pretation of the data. White women exhibited an increase in log transformed vitamin D concentration
of 0.116 when compared to mulatto or black women. Nevertheless, this variable did not interfere with
cord vitamin D concentration.
Almost 9% of the women reported vitamin D supplementation during pregnancy. As in Brazil,
vitamin D supplementation is not part of the antenatal care protocol in other countries. However, in
this study, vitamin D supplementationwas the variable that had the largest impact on log transformed
maternal vitamin D concentration, contributing to an increase of 0.614 in the vitamin. Despite the lack
of studies investigating vitamin D status in pregnant Brazilian women, we are encouraged to reﬂect
about the need and beneﬁts of implementing vitamin D supplementation as part of the antenatal care
protocol in viewof the high prevalence of vitamin D insufﬁciency/deﬁciency in the Brazilian population
[26,27].
Physical activity during pregnancy, which was low in most of the women participating in the study
(42.6%), can have a protective effect against vitamin D deﬁciency. In cases of outdoor physical activities,
this effect has been attributed to sun exposure and to the season of the year when the blood sample
was collected [28]. In the present study, blood was collected during the same season of the year
(autumn), but we did not determine whether physical activity was performed outdoors or indoors.
Since walking is the most common physical activity performed by Brazilian adults, we believe that part
of the participants walked outdoors, generally in public parks where sunlight is readily available in
autumn. This fact would explain the association between physical activity and maternal vitamin D
concentration. Based on the results of this study it is important to implement interventions to increase
outdoor physical activity in Brazil.
Table 2
Multivariate linear regression model considering log transformed maternal vitamin D concentration as outcome and maternal
adiposity as independent variable.
Variables b CI (95%) P Adj. R2
Race 0.116 0.021e0.211 0.017
Level of physical activity 0.290 0.074e0.051 0.009
Vitamin D supplementation 0.614 0.097e1.131 0.020
Constant 2.628 2.226e2.230 <0.001 0.737
Adjusted for the following confounders: maternal age, race, physical activity, parity, height, pre-pregnancy BMI, weight gain and
vitamin D supplementation in pregnancy.
Table 3
Multivariate linear regression model, considering log transformed cord vitamin D concentration as outcome and maternal
adiposity as independent variable.
Variable b CI (95%) P Adj. R2
Maternal vitamin D concentration 0.078 0.013e0.143 0.019
Constant 0.719 0.506e0.931 <0.001 0.235
Adjusted for the following confounders: maternal age, race, physical activity, parity, height, pre-pregnancy BMI, weight gain and
vitamin D supplementation in pregnancy, maternal vitamin D concentration, GA, and newborn's sex, weight, length and fat mass
percentage.
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ability of the placenta to transport this vitamin [14]. However, there is no evidence that obesity or
maternal adiposity impairs vitamin D transport through the placenta. To our knowledge, this is the ﬁrst
study that evaluated the relationship between maternal adiposity and cord blood vitamin D concen-
tration, reporting no association between these variables. In addition, no association was found be-
tween pre-pregnancy BMI and cord blood vitamin D concentration.
It is important to note that conditions that affect maternal vitamin D transport to the foetus, such as
drug, tobacco and alcohol use, hyperglycaemia, hypertension, preterm/post-term deliveries and
adolescent pregnancy, were excluded from the study. One may speculate that maternal adiposity/
obesity per se does not interferewithmaternal vitamin D transport to the foetus in the absence of other
associated conditions.
Bioelectrical impedance, the method used in this study to assess maternal body composition, has
limitations when applied during pregnancy and shortly after delivery because of an altered relation-
ship between intracellular and extracellular water and higher water content in the trunk compared to
other body segments [29]. However, Karlsson et al. [15] obtained similar results using air displacement
plethysmography to estimate maternal body composition, indicating that maternal adiposity may not
interfere with maternal or cord blood vitamin D concentration during pregnancy, regardless of the
method used.
Inadequate vitamin D intake during pregnancy is frequently reported in cross-sectional and lon-
gitudinal studies [30] and has been implicated in low maternal and cord blood vitamin D concentra-
tions. Prenatal nutritional counselling is important to stimulate adequate vitamin D consumption, by
increasing the intake of vitamin D-rich foods such as fatty ﬁsh, liver, eggs, vegetables and fortiﬁed dairy
products.
In conclusion, this study shows that maternal adiposity was not associated with maternal or cord
blood concentration of vitamin D. However, maternal vitamin D concentration was positively associ-
ated with cord vitamin D concentration, conﬁrming the results of previous studies.
Although fat mass quantiﬁcation is important to understand vitamin D status during all stages of
life, this might not be true in pregnancy as race, vitamin D supplementation and physical activity
appeared to be more relevant to vitamin D status. Understanding how vitamin D metabolism changes
during pregnancy may shed light on how or if adiposity inﬂuences vitamin D status in pregnancy. In
addition, it would be relevant to explore in a further study vitamin D-binding protein concentrations
and genetic polymorphisms in vitamin D receptor.
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